Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability and preliminary efficacy of an erythrocyte-anchored PD-1 conjugate in patients with advanced malignancies, includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hematologic Malignancy
• Solid Tumor

Drugs mentioned

• Erythrocyte-αPD-1 Conjugate (erythrocyte-anchored PD-1 conjugate)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Cancer, Solid Tumor | Phase 1 | Status: NOT_YET_RECRUITING